vs
Andersons, Inc.（ANDE）与福尼克斯（PLAB）财务数据对比。点击上方公司名可切换其他公司
Andersons, Inc.的季度营收约是福尼克斯的1.6倍（$329.5M vs $210.4M），Andersons, Inc.净利率更高（20.5% vs 10.9%，领先9.6%），Andersons, Inc.同比增速更快（-2.4% vs -5.5%），福尼克斯自由现金流更多（$25.2M vs $-77.1M），过去两年Andersons, Inc.的营收复合增速更高（-1.8% vs -3.8%）
安德森公司（The Andersons, Inc.）是1947年成立的美国农业企业，总部位于俄亥俄州莫米。公司起源于1940年代服务粮食行业的安德森货运站，是深耕农业领域的多元化企业，业务覆盖大宗商品贸易、可再生能源以及植物营养板块。
福尼克斯是美国半导体光掩模制造商，2009年时位居全球第三大光掩模供应商，同时也是电子束产业倡议组织的成员，专注于为半导体行业提供关键的掩模产品，支撑芯片制造环节的图形转移需求。
ANDE vs PLAB — 直观对比
营收规模更大
ANDE
是对方的1.6倍
$210.4M
营收增速更快
ANDE
高出3.1%
-5.5%
净利率更高
ANDE
高出9.6%
10.9%
自由现金流更多
PLAB
多$102.3M
$-77.1M
两年增速更快
ANDE
近两年复合增速
-3.8%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $329.5M | $210.4M |
| 净利润 | $67.4M | $22.9M |
| 毛利率 | 70.3% | 33.7% |
| 营业利润率 | 26.6% | 22.9% |
| 净利率 | 20.5% | 10.9% |
| 营收同比 | -2.4% | -5.5% |
| 净利润同比 | 49.6% | -32.4% |
| 每股收益（稀释后） | — | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANDEPLAB
| Q4 25 | $329.5M | — | ||
| Q3 25 | $295.8M | $210.4M | ||
| Q2 25 | $535.0M | $211.0M | ||
| Q1 25 | $370.8M | $212.1M | ||
| Q4 24 | $337.5M | $222.6M | ||
| Q3 24 | $231.9M | $211.0M | ||
| Q2 24 | $492.5M | $217.0M | ||
| Q1 24 | $341.4M | $216.3M |
净利润ANDEPLAB
| Q4 25 | $67.4M | — | ||
| Q3 25 | $20.1M | $22.9M | ||
| Q2 25 | $7.9M | $8.9M | ||
| Q1 25 | $284.0K | $42.9M | ||
| Q4 24 | $45.1M | $33.9M | ||
| Q3 24 | $27.4M | $34.4M | ||
| Q2 24 | $36.0M | $36.3M | ||
| Q1 24 | $5.6M | $26.2M |
毛利率ANDEPLAB
| Q4 25 | 70.3% | — | ||
| Q3 25 | 57.8% | 33.7% | ||
| Q2 25 | 29.6% | 36.9% | ||
| Q1 25 | 41.2% | 35.6% | ||
| Q4 24 | 63.1% | 37.0% | ||
| Q3 24 | 76.4% | 35.6% | ||
| Q2 24 | 35.6% | 36.5% | ||
| Q1 24 | 37.6% | 36.6% |
营业利润率ANDEPLAB
| Q4 25 | 26.6% | — | ||
| Q3 25 | 8.7% | 22.9% | ||
| Q2 25 | 4.6% | 26.4% | ||
| Q1 25 | 0.9% | 24.6% | ||
| Q4 24 | 19.9% | 25.1% | ||
| Q3 24 | 26.8% | 24.7% | ||
| Q2 24 | 11.6% | 25.8% | ||
| Q1 24 | 4.1% | 26.6% |
净利率ANDEPLAB
| Q4 25 | 20.5% | — | ||
| Q3 25 | 6.8% | 10.9% | ||
| Q2 25 | 1.5% | 4.2% | ||
| Q1 25 | 0.1% | 20.2% | ||
| Q4 24 | 13.4% | 15.2% | ||
| Q3 24 | 11.8% | 16.3% | ||
| Q2 24 | 7.3% | 16.7% | ||
| Q1 24 | 1.6% | 12.1% |
每股收益（稀释后）ANDEPLAB
| Q4 25 | — | — | ||
| Q3 25 | $0.59 | $0.39 | ||
| Q2 25 | $0.23 | $0.15 | ||
| Q1 25 | $0.01 | $0.68 | ||
| Q4 24 | $1.31 | $0.54 | ||
| Q3 24 | $0.80 | $0.55 | ||
| Q2 24 | $1.05 | $0.58 | ||
| Q1 24 | $0.16 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.3M | $575.8M |
| 总债务越低越好 | $560.0M | $16.0K |
| 股东权益账面价值 | $1.2B | $1.1B |
| 总资产 | $3.7B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.45× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ANDEPLAB
| Q4 25 | $98.3M | — | ||
| Q3 25 | — | $575.8M | ||
| Q2 25 | — | $558.4M | ||
| Q1 25 | — | $642.2M | ||
| Q4 24 | $561.8M | $640.7M | ||
| Q3 24 | — | $606.4M | ||
| Q2 24 | — | $559.9M | ||
| Q1 24 | — | $521.5M |
总债务ANDEPLAB
| Q4 25 | $560.0M | — | ||
| Q3 25 | — | $16.0K | ||
| Q2 25 | — | $19.0K | ||
| Q1 25 | — | $21.0K | ||
| Q4 24 | $608.2M | $25.0K | ||
| Q3 24 | — | $28.0K | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $2.7M |
股东权益ANDEPLAB
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.4B | $1.1B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $1.3B | $1.0B | ||
| Q1 24 | $1.3B | $1.0B |
总资产ANDEPLAB
| Q4 25 | $3.7B | — | ||
| Q3 25 | $3.3B | $1.8B | ||
| Q2 25 | $3.4B | $1.7B | ||
| Q1 25 | $3.8B | $1.7B | ||
| Q4 24 | $4.1B | $1.7B | ||
| Q3 24 | $3.4B | $1.6B | ||
| Q2 24 | $3.3B | $1.6B | ||
| Q1 24 | $3.3B | $1.6B |
负债/权益比ANDEPLAB
| Q4 25 | 0.45× | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | 0.45× | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.2M | $50.1M |
| 自由现金流经营现金流 - 资本支出 | $-77.1M | $25.2M |
| 自由现金流率自由现金流/营收 | -23.4% | 12.0% |
| 资本支出强度资本支出/营收 | 21.5% | 11.8% |
| 现金转化率经营现金流/净利润 | -0.09× | 2.19× |
| 过去12个月自由现金流最近4个季度 | $-56.1M | $64.5M |
8季度趋势，按日历期对齐
经营现金流ANDEPLAB
| Q4 25 | $-6.2M | — | ||
| Q3 25 | $233.9M | $50.1M | ||
| Q2 25 | $299.3M | $31.5M | ||
| Q1 25 | $-350.0M | $78.5M | ||
| Q4 24 | $268.8M | $68.4M | ||
| Q3 24 | $-2.1M | $75.1M | ||
| Q2 24 | $304.4M | $76.5M | ||
| Q1 24 | $-239.6M | $41.5M |
自由现金流ANDEPLAB
| Q4 25 | $-77.1M | — | ||
| Q3 25 | $167.0M | $25.2M | ||
| Q2 25 | $250.5M | $-29.1M | ||
| Q1 25 | $-396.6M | $43.3M | ||
| Q4 24 | $212.9M | $25.2M | ||
| Q3 24 | $-40.0M | $50.7M | ||
| Q2 24 | $275.8M | $56.5M | ||
| Q1 24 | $-266.4M | $-1.8M |
自由现金流率ANDEPLAB
| Q4 25 | -23.4% | — | ||
| Q3 25 | 56.5% | 12.0% | ||
| Q2 25 | 46.8% | -13.8% | ||
| Q1 25 | -106.9% | 20.4% | ||
| Q4 24 | 63.1% | 11.3% | ||
| Q3 24 | -17.2% | 24.0% | ||
| Q2 24 | 56.0% | 26.0% | ||
| Q1 24 | -78.0% | -0.8% |
资本支出强度ANDEPLAB
| Q4 25 | 21.5% | — | ||
| Q3 25 | 22.6% | 11.8% | ||
| Q2 25 | 9.1% | 28.7% | ||
| Q1 25 | 12.6% | 16.6% | ||
| Q4 24 | 16.6% | 19.4% | ||
| Q3 24 | 16.3% | 11.6% | ||
| Q2 24 | 5.8% | 9.2% | ||
| Q1 24 | 7.8% | 20.0% |
现金转化率ANDEPLAB
| Q4 25 | -0.09× | — | ||
| Q3 25 | 11.61× | 2.19× | ||
| Q2 25 | 38.10× | 3.55× | ||
| Q1 25 | -1232.46× | 1.83× | ||
| Q4 24 | 5.96× | 2.02× | ||
| Q3 24 | -0.08× | 2.18× | ||
| Q2 24 | 8.46× | 2.11× | ||
| Q1 24 | -42.94× | 1.59× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
